Strata Critical Medical, Inc. 8-K

What Happened

• Strata Critical Medical, Inc. announced on May 6, 2026 that it issued a press release reporting its financial results for the quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K and is incorporated by reference. The report was signed by William A. Heyburn, Co‑Chief Executive Officer and Chief Financial Officer.

Key Details

• Filing date: May 6, 2026 (Form 8-K).
• Reporting period: Quarter ended March 31, 2026 (Q1 2026).
• Exhibit included: Press Release dated May 6, 2026 (Exhibit 99.1) and Cover Page Interactive Data File (Inline XBRL, Exhibit 104).
• 8-K items reported: Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).

Why It Matters

• This 8-K notifies investors that Strata has released its quarterly earnings and operational results; the press release will contain the specific revenue, profit/loss, cash position, and any commentary management provides. Investors should review the Exhibit 99.1 press release and company disclosures to assess the company’s recent performance and any implications for guidance, liquidity, or near-term operations.